info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0151566-01
Couldn't load pickup availability
AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD) [1].
[319460-94-1]
C26H22FN7O
467.5
O=C(C1=CC(C)=NN1C)NC2=CC(NC3=CC4=C(C=C3)C(/C=C/C5=NC=CC=C5)=NN4)=CC=C2F
VEGFR
10mM
99.71
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
4°C (Powder, protect from light)
Room Temperature
H302-H315-H319-H335
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
Loading...
Total items
Product subtotal
AG-13958 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.